Hepatic dysfunction, most commonly an elevation of aminotransferases, develops in 15% to
40% of patients receiving amiodarone (1). However, acute hepatitis induced by parenteral …

Acute hepatitis after parenteral amiodarone Page 1 Br Heart J 1988;59:690-1 Acute
hepatitis after parenteral amiodarone adnministration M PYE, Rj NORTHCOTE, SM COBBE …

Acute hepatitis is a very rare, but potentially fatal, adverse effect of intravenous amiodarone.
We present a case of an 88-year-old man with history of ischemic dilated cardiomyopathy …

A patient with acute changes suggesting acute hepatitis after parenteral amiodarone
administration is described. A 77‐year‐old man with previous myocardial infarction was …

Two patients with acute changes suggesting acute hepatitis after parenteral amiodarone
administration are described. No other explanation for liver damage was found in these …

The evolving spectrum of amiodarone hepatotoxicity Page 1 HEPATOLOGY 116 HEPATOLOGY
ELSEWHERE timately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl …

Amiodarone chlorhydrate is a diiodated benzofuran derivative used to treat cardiac rhythm
abnormalities. Hepatotoxicity is a relatively uncommon side effect of amiodarone and …

The antiarrhythmic agent amiodarone is associated with numerous adverse effects, but
clinically significant liver disease is rare. A patient is described who presented with muscle …

Abstract Background and Aims: Hepatotoxic complications of long-term oral amiodarone
therapy have been well described; however, liver injury secondary to parenteral infusion of …

Amiodarone is one of the most effective antiarrhythmic drugs available and is widely
prescribed despite several potentially life-threatening side-effects. Hepatotoxicity is the most …